Theraclion SA (EPA:ALTHE)
0.6080
-0.0020 (-0.33%)
Jan 12, 2026, 11:39 AM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €28.66 million as of January 12, 2026. Its market cap has increased by 88.11% in one year.
Market Cap
28.66M
Enterprise Value
32.07M
Revenue
1.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.61
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 28.66M, a decrease of -23.64%. That is a compound annual growth rate of -2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 28.66M | 1.33% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |